Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Quantum Dot Corporation Launches Mosaic™

New tool for pharmaceutical, biotechnology and functional genomics researchers

Quantum Dot Corporation Launches the Mosaic™ Gene Expression Assay System: a Unique Combination of Quality Controls, Performance and Throughput for Multiplexed mRNA Quantification

Hayward, CA | March 21, 2005

Quantum Dot Corporation announces launch of the Mosaic Gene Expression Assay System. For the first time, pharmaceutical, biotechnology and functional genomics researchers can measure quantitative expression of 100 user-specified mRNAs simultaneously from small amounts of input sample. The Mosaic System offers a unique combination of features, including:

  • Custom multiplex of 100 user-specified genes; 200 genes will be available later in 2005
  • Calibrators and assay quality controls built into every assay
  • Exceptional technical performance
           o Sensitivity comparable to qPCR with better precision
           o Measure less than 1.4-fold changes in mRNA expression
  • High throughput for large projects: 360 samples of 100 genes per sample in 24 hours

“The combination of quality controls in every assay, exceptional performance, throughput and project cost savings brings tremendous benefit to researchers and a better way to implement gene expression analysis for discovery, compound screening and lead validation,” cites Senior Marketing Manager, Stephen Chamberlain, Ph.D.

The Mosaic System includes the Mosaic Q1000 Scanner and computer, Mosaic software, and custom Gene Panels configured in convenient kit format; the assay is designed for automated processing on liquid-handling workstations. Each custom Gene Panel is designed and manufactured with gene-specific beads that are spectrally coded with the QDC’s innovative Qdot® nanocrystals. Fluorescent spectral codes are identified and gene data is measured by the Mosaic Q1000 Scanner and analyzed by the Mosaic Data Collector and Expression Manager Software modules.

Quantum Dot CEO, George Dunbar explains, “This cutting edge technology, combined with QDC’s Qdot nanocrystal expertise, not only allows scientists to perform fine gene expression research on the most important subsets of genes for compound discovery and development, but also satisfies new demands in emerging fields such as Translational and Molecular Medicine.”

About Quantum Dot Corporation
Quantum Dot Corporation (QDC) is a privately held bioscience company that pioneered the development and commercialization of Qdot® nanocrystals for bio-detection in discovery and clinical applications. QDC’s current products include life-science kits and applications used by academic and pharmaceutical-discovery laboratories worldwide. In addition, QDC recently launched its first integrated instrumentation, software, and bio-reagents platform, the Mosaic™ System, for rapid and quantitative multiplexed gene expression analysis. QDC collaborates with leading academic and industrial partners and has over 150 patents and patentspending. For more information, visit

George Dunbar
CEO, Quantum Dot Corporation
(510) 887 8775, ext. 4101

Gayle Kuokka
CFO, Quantum Dot Corporation
(510) 887 8775, ext. 4199

Copyright © Quantum Dot Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Scientists design a QKD-based quantum private query with no failure November 25th, 2015

MIT mathematicians identify limits to heat flow at the nanoscale: New formula identifies limits to nanoscale heat transfer, may help optimize devices that convert heat to electricity November 25th, 2015

Physicists explain the unusual behavior of strongly disordered superconductors: Using a theory they developed previously, the scientists have linked superconducting carrier density with the quantum properties of a substance November 25th, 2015

Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015


Using light-force to study single molecules November 23rd, 2015

Breakthrough allows tracking of single molecules in 3-D with nanoscale accuracy:New method builds on Nobel Prize-winning technique, with exciting implications for understanding the inner workings of cells and neurons November 23rd, 2015

UCLA nanoscientists develop safer, faster way to remove pollutants from water November 23rd, 2015

New EU project designed to link diagnosis and treatment of diseases over the long term: Joint research project aims at the improvement of companion diagnostics and therapy of tumor diseases November 23rd, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic